Erisbeg

Overview

Erisbeg is a private equity firm based in Dublin, Ireland, focusing on acquiring and further developing established businesses in Ireland and the United Kingdom. The firm primarily targets companies in sectors such as healthcare supplies, pharmaceutical distribution, compliance and regulatory technology, and critical communications. Erisbeg seeks to partner with existing management teams to drive growth both organically and through strategic acquisitions. The firm's investment strategy involves taking majority stakes, typically ranging from €3 million to €40 million, with a holding period of five to seven years. Erisbeg emphasizes a collaborative approach, aiming to augment the skills of existing management and support them in achieving new heights. The firm has a track record of successful investments, including the acquisition of a majority stake in CHM Group, Ireland's leading traffic management solutions provider, in February 2025. Erisbeg's team comprises experienced entrepreneurs and industry veterans with backgrounds in sectors such as credit derivatives, environmental waste management, software, healthcare, and corporate mergers and acquisitions. This diverse expertise enables the firm to provide hands-on support to portfolio companies, assisting them in navigating challenges and capitalizing on growth opportunities. The firm's commitment to excellence and integrity is reflected in its long-term investment approach and focus on building trust-based partnerships with business owners.